Statement Of Unitholders' Equity

D.Western Therapeutics Institute, Inc. - Filing #7272873

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Statement of unitholders' equity
Statement of unitholders' equity
Net assets
1,788,000 JPY
1,788,000 JPY
-34,000 JPY
0 JPY
0 JPY
3,302,619,000 JPY
3,302,619,000 JPY
1,203,277,000 JPY
-34,000 JPY
3,261,516,000 JPY
733,869,000 JPY
-3,821,200,000 JPY
684,695,000 JPY
-3,732,678,000 JPY
-3,821,200,000 JPY
-34,000 JPY
686,449,000 JPY
1,203,277,000 JPY
732,115,000 JPY
-34,000 JPY
699,000 JPY
699,000 JPY
JPY
-36,000 JPY
-36,000 JPY
831,617,000 JPY
-2,442,372,000 JPY
-2,481,343,000 JPY
1,281,233,000 JPY
2,930,959,000 JPY
2,930,959,000 JPY
0 JPY
-2,481,343,000 JPY
0 JPY
1,279,764,000 JPY
831,617,000 JPY
-36,000 JPY
1,279,101,000 JPY
-36,000 JPY
2,889,857,000 JPY
1,281,896,000 JPY
943,000 JPY
-222,000 JPY
-222,000 JPY
JPY
-222,000 JPY
1,873,475,000 JPY
-1,628,138,000 JPY
JPY
714,244,000 JPY
714,244,000 JPY
-1,628,138,000 JPY
15,987,000 JPY
1,856,767,000 JPY
1,900,413,000 JPY
-222,000 JPY
2,772,484,000 JPY
2,813,586,000 JPY
2,813,586,000 JPY
1,899,692,000 JPY
-1,629,961,000 JPY
943,000 JPY
Changes during period
Net changes in items other than shareholders' equity
1,089,000 JPY
1,000 JPY
1,000 JPY
1,000 JPY
1,090,000 JPY
1,090,000 JPY
1,000 JPY
1,089,000 JPY
-244,000 JPY
-244,000 JPY
-15,987,000 JPY
-16,045,000 JPY
185,000 JPY
185,000 JPY
185,000 JPY
185,000 JPY
-58,000 JPY
Total changes during period
1,089,000 JPY
1,000 JPY
371,659,000 JPY
-596,538,000 JPY
1,000 JPY
371,659,000 JPY
1,000 JPY
JPY
JPY
-595,447,000 JPY
-545,895,000 JPY
-546,986,000 JPY
371,659,000 JPY
371,659,000 JPY
1,000 JPY
-1,290,305,000 JPY
-1,339,857,000 JPY
-1,339,857,000 JPY
371,659,000 JPY
1,089,000 JPY
-244,000 JPY
-244,000 JPY
-15,987,000 JPY
-593,711,000 JPY
-853,205,000 JPY
0 JPY
185,000 JPY
-577,665,000 JPY
117,373,000 JPY
117,373,000 JPY
185,000 JPY
-853,205,000 JPY
185,000 JPY
117,373,000 JPY
185,000 JPY
-812,411,000 JPY
-618,459,000 JPY
117,373,000 JPY
-618,517,000 JPY
0 JPY
117,373,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.